Pfizer Inc. (PFE) stock
Pfizer Inc. (PFE) trades on NYSE and is classified in the Healthcare sector. Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor. This page tracks PFE using verified market data, the company's most recently reported financial statements, its earnings record and Ticker-Terminal's analytical models. Every figure is shown with its source and the time it was last verified, and values we cannot verify are labelled rather than filled in.
Previous close
$29.46
Volume
34,172,429
52-week range
$23.62 – $30.44
Market cap
$167.86B
Source: Polygon (snapshot) · Verified Oct 29, 2026, 6:03 PM EDT
Performance
1D
+2.11%
1W
-1.55%
1M
+4.28%
1Y
+23.30%
Percentage change calculated from verified closing prices. Periods without full provider coverage are marked unavailable rather than estimated.
Reported financials
Verified · 86 days agoRevenue (TTM)
Reported Q2'26 · Polygon (company financials)
Revenue growth (YoY)
Reported Q2'26 · Polygon (company financials)
EPS (TTM, diluted)
Reported Q2'26 · Polygon (company financials)
EPS growth (YoY)
Reported Q2'26 · Polygon (company financials)
Gross margin
Reported Q2'26 · Polygon (company financials)
Operating margin
Reported Q2'26 · Polygon (company financials)
Net margin
Reported Q2'26 · Polygon (company financials)
Operating cash flow (TTM)
Reported Q2'26 · Polygon (company financials)
Revenue 2-year CAGR
Reported Q2'26 · Polygon (company financials)
Source: Polygon financials + Finnhub earnings · Latest reported Q2'26 · Verified Aug 3, 2026, 8:00 PM EDT
Valuation
P/E (trailing)
Reported Q2'26 · Ticker-Terminal (last verified price ÷ TTM diluted EPS)
P/E (forward, est.)
Ticker-Terminal (last verified price ÷ annualised consensus EPS estimate)
Market cap
Polygon / Finnhub reference
Dividend yield
Ticker-Terminal does not publish a dividend yield for this ticker until a verified distribution is on file.
Earnings
Verified · 86 days agoNext earnings date
Nov 2, 2026
Source: Finnhub earnings calendar
Latest reported quarter
Q2'26
Revenue $15.03B · Diluted EPS -0.04
| Period | EPS actual | Estimate | Surprise |
|---|---|---|---|
| 2026-06-30 | 0.77 | 0.69 | +11.4% |
| 2026-03-31 | 0.75 | 0.72 | +3.5% |
| 2025-12-31 | 0.66 | 0.58 | +14.3% |
| 2025-09-30 | 0.87 | 0.64 | +36.0% |
Ticker-Terminal analysis of PFE
Earnings-power range
Bear $12.26 · Base $15.33 · Bull $18.40 — Significantly Overvalued versus the last verified price.
Bull case
Sustained growth and margin strength support roughly $18.40.
- Applies a 15× earnings multiple to trailing diluted EPS of 1.05, plus a 20% upside band.
- Latest reported revenue growth: 2.6% year over year.
- Operating margin could not be verified.
Base case
Current reported earnings power maps to roughly $15.33 (significantly overvalued versus the last verified price).
- Earnings-power estimate: trailing diluted EPS × a growth-adjusted 15× multiple.
- Implied difference versus the last verified price: -49.0%.
- Trailing operating cash flow: $13.40B.
Bear case
Multiple compression or slowing growth maps to roughly $12.26.
- Applies a 20% downside band to the earnings-power estimate.
- Latest reported EPS growth: -107.8% year over year.
- Downside from the last verified price in this scenario: -59.2%.
Calculated from verified reported financials and the last verified price (data verified Oct 29, 2026, 6:03 PM EDT). Analytical model output, not a price target or investment advice.
Analyst consensus
UnavailableRating
Hold
Average target
Unavailable
Range
Unavailable
Analysts
33
Source: finnhub
Recent PFE news
Verified · 10 hours ago- Exploring Analyst Estimates for Pfizer (PFE) Q3 Earnings, Beyond Revenue and EPS
Yahoo Finance · Oct 29, 2026
- Pfizer (PFE) Scores Phase 3 Cancer Win As FDA Broadens Another Oncology Approval
Yahoo Finance · Oct 27, 2026
- Pfizer Announces That Topline Results In The Phase 3 MagnetisMM-32 Trial Of ELREXFIO Demonstrated Clinically Meaningful And Statistically Significant Benefit For Patients Whose Disease Progressed After Anti-CD38 Therapy And Lenalidomide, With Median PFS Not Yet Reached
Benzinga · Oct 27, 2026
- Pfizer (PFE) Stock Sinks As Market Gains: Here's Why
Yahoo Finance · Oct 28, 2026
- Pfizer (PFE) Expected to Beat Earnings Estimates: Should You Buy?
Yahoo Finance · Oct 27, 2026
- Pfizer’s ELREXFIO Outperforms Standard Regimens and Meets Primary Endpoint in Phase 3 Study in Relapsed or Refractory Multiple Myeloma
Yahoo Finance · Oct 27, 2026
Data confidence: Partial confidence
Some data is delayed, stale or unavailable. Everything shown is still verified.
- 1 financial metric unavailable.
Still fully reliable
Company profile and business overview · Reported financial statements · Earnings history · Ticker-Terminal analysis
PFE in its sector
Run full AI research on PFE
This page is the free public summary. Inside Ticker-Terminal you get quarterly forecasts, EPS estimate tracking, earnings deep dives, fair-value modelling and AI research built on the same verified provider data and filings.
PFE questions, answered
What does Pfizer Inc. do?
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Where is PFE listed?
Pfizer Inc. trades under the ticker PFE on NYSE.
What is the PFE stock price today?
PFE was last verified at $30.08 (2.11% on the day). After hours, last verified Oct 29, 2026, 6:03 PM EDT. Market data may be delayed and is shown with its own timestamp.
Is Pfizer Inc. revenue growing?
Based on the latest reported financials, PFE revenue changed 2.6% year over year (filed Aug 3, 2026).
When does Pfizer Inc. report earnings next?
The next confirmed PFE earnings date is Nov 2, 2026, per Finnhub earnings calendar. Dates can be revised by the company.
What did Pfizer Inc. report in its latest quarter?
For Q2'26, PFE reported revenue of $15.03B and diluted EPS of -0.04.
What is Ticker-Terminal's PFE growth score?
Ticker-Terminal scores PFE at 33/100 (F) from verified growth, profitability, financial strength and valuation inputs. It is an analytical model based on available verified data, not a guarantee of future performance.
How can I run deeper AI research on PFE?
Create a free Ticker-Terminal account to run a full AI research report on PFE — earnings breakdown, quarterly forecasts, bull, base and bear cases, and fair value ranges built on verified provider data and filings.
Learn how to read this
Free guide series
Get the “how to research a stock” checklist
Two emails. The 7-step checklist now, then the next guide in the series — starting with Which AI is best for stock research.
- The 7-step “how to research a stock” checklist, sent immediately
- The next recommended guide in the series, two days later
- Occasional new guides only — no daily market noise, unsubscribe in one click
Market data on this page is supplied by third-party providers, may be delayed, and is shown with the time it was last verified. Financial figures come from PFE's most recently reported statements and are not restated by Ticker-Terminal.
Scores, fair-value ranges and bull, base and bear scenarios are analytical models calculated from verified data. They are educational information, not investment advice, not a price prediction, and not a recommendation to buy or sell any security. Past performance does not indicate future results.
See our risk disclosure. Page data assembled Oct 29, 2026, 6:19 PM EDT.